Final clinical and molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion: NCT00626990.
Martin J. van den Bent, Sara Erridge, Michael A. Vogelbaum, Anna K. Nowak et autres
5 citationsJournal of Clinical Oncology